why choose us

Clinical Trials Search

Showing 2,030 of 131,434 result(s)
Parkinson's Disease Biomarker Study

Status: COMPLETED

Condition: Parkinson Disease, Idiopathic

Interventions: Observational

Date: 2025-02-02

Nonsurgical Periodontal Treatment Combined With Anti-TNF-? in Patients With Rheumatoid Arthritis and Periodontitis

Status: COMPLETED

Condition: Peridontal Disease

Interventions: This procedure will be applied to all patients.
All patients received nonsurgical periodontal treatment.
Scaling root planing and subgingiva

Date: 2025-02-02

Effectiveness of a 3-month Individual Reminiscence Therapy Program in Older Adults With Alzheimer's Disease

Status: COMPLETED

Condition: Dementia

Interventions: Intervention group will receive two RT sessions per week for 13 weeks.
RT sessions will last approximately 50 minutes and will be developed accor

Date: 2025-02-02

Paceport Swan-Ganz Data Collection Study

Status: COMPLETED

Condition: RV Dysfunction

Interventions: This is an observational study

Date: 2025-02-02

The Effect of Metformin As an Adjuvant Therapy on Immunological Parameters in Egyptian Patients with RRMS: a Pilot Study

Status: COMPLETED

Condition: Multiple Sclerosis (MS) - Relapsing-remitting

Interventions: Antidiabetic agent used to treat type 2 diabetes, and to prevent type 2 diabetes.

Date: 2025-02-02

Progesterone Primed Ovarian Stimulation Versus GnRH Antagonist Protocols in Women with Polycystic Ovarian Syndrome

Status: COMPLETED

Condition: Controlled Ovarian Hyperstimulation

Interventions: compare the use of the progesterone-primed ovarian stimulation protocol versus GnRH antagonist protocol in women with polycystic ovarian syndrome (PCO

Date: 2025-02-02

High-dose Furmonertinib Combined With Bevacizumab and Intrathecal Pemetrexed Chemotherapy in Patients With EGFR-mutated Non-small Cell Lung Cancer and Meningeal Metastasis

Status: COMPLETED

Condition: Non-small Cell Lung Cancer Metastatic

Interventions: furmonertinib (160mg, once a day, continuous administration); bevacizumab (7.5 mg;kg body weight, once every 3 weeks); Pemetrexed (50 mg intrathe

Date: 2025-02-02

Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

Status: COMPLETED

Condition: Hypoxia

Interventions: Using the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

Date: 2025-02-01

Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

Status: COMPLETED

Condition: Hypoxia

Interventions: Using the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

Date: 2025-02-01

Efficacy of Propofol-Ketamine and Sevoflurane in Children Undergoing Magnetic Resonance Imaging

Status: COMPLETED

Condition: Recovery Period

Interventions: For Group S, 8% sevoflurane was administered for induction via the procedural oxygen mask for 2 minutes through the external output of the anesthesia

Date: 2025-02-01